Patents in Brazil: an overview for foreign businesses
A patent in Brazil protects inventions that are new, involve an inventive step and have industrial application. It is granted and examined by the Brazilian INPI, the national industrial property office. Brazil is first-to-file, accepts Paris priority and PCT national-phase entry, and requires ANVISA prior consent for pharmaceutical applications.
Brazil is the largest economy in Latin America and a priority filing destination for businesses expanding into the region. Its patent system is administered by the Brazilian INPI (Instituto Nacional da Propriedade Industrial), which examines applications substantively before grant. Note that this is Brazil's office and is a different body from the French INPI, which shares the same acronym. This page gives a practical overview of how patents work in Brazil for businesses based elsewhere. It is general information rather than legal advice, and the specific steps for your situation are covered in our guide to filing a patent in Brazil and in the wider Brazil jurisdiction overview.
What a patent protects in Brazil
A Brazilian patent of invention protects a technical creation that meets three core requirements. The invention must be novel (new against everything publicly available anywhere before the filing or priority date), it must involve an inventive step (it would not have been obvious to a person skilled in the field), and it must have industrial application (it can be made or used in some kind of industry). These thresholds will be familiar from most major patent systems, though the Brazilian INPI applies them under its own law and examination practice, and certain subject matter is excluded or treated specially. If your invention sits in software, biotechnology or methods, eligibility is jurisdiction-specific and worth checking with local counsel early rather than assuming it tracks how the same invention is treated at home.
Portuguese is the filing language in Brazil, and foreign applicants without a domicile in the country generally need to appoint a local representative (an attorney or industrial property agent based in Brazil) to act before the office. This is a practical gateway requirement, so factor representation into your planning from the outset.
The Brazilian INPI and the examination backlog
The Brazilian INPI conducts substantive examination, which is part of why a granted Brazilian patent is treated as a meaningful right. Historically the office was known for very long pendency, with patent and trade mark applications taking many years to reach a decision. That backlog has been a real planning factor for foreign applicants. The position has been improving: the office has run programmes aimed at reducing the backlog and speeding up examination, and reported pendency has come down over recent years. The current state of the backlog and any acceleration programmes change over time, so treat timelines as confirm-with-counsel rather than fixed, and confirm the current position with the Brazilian INPI or local counsel.
Brazil joined the Madrid Protocol in 2019, and around that accession its trade mark practice was modernised (multi-class applications and co-ownership were introduced as the related functionality came online), reflecting a broader direction of travel towards alignment with international systems. On the designs side, Brazil acceded to the Hague system for industrial designs, which came into force for the country in 2023. These are useful context points: the Brazilian system has been moving towards greater international integration, though the detail of how each treaty operates locally should always be checked.
First-to-file and the priority date
Brazil is a first-to-file jurisdiction. Where two applicants file for the same invention, the earlier filing date prevails, regardless of who invented first. The practical consequence is the same everywhere first-to-file applies: file before you disclose, and file promptly, because public disclosure before your filing or priority date can destroy novelty. Brazilian law does recognise a limited grace period for certain disclosures by or deriving from the applicant, but the conditions and the procedural steps to rely on it are specific, so do not treat it as a substitute for filing first; confirm the current rules with the Brazilian INPI or local counsel before disclosing anything.
If you are filing internationally, you will usually rely on a Paris Convention priority claim from your first application elsewhere, which lets you file in Brazil while keeping your original date. That priority window is a statutory period and should be confirmed with the Brazilian INPI or local counsel rather than assumed.
Pharmaceutical patents and ANVISA prior consent
Brazil has a distinctive rule for pharmaceutical inventions. Applications relating to pharmaceutical products and processes require prior consent (anuencia previa, a simplified ASCII rendering of the Portuguese term for prior approval) from ANVISA, the National Health Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria), in addition to examination by the Brazilian INPI. This means a pharmaceutical patent application passes through two bodies rather than one, and the interaction between the health regulator's review and the patent office's examination has its own procedure and history of debate. The scope of what falls within ANVISA's remit, and how the two reviews are sequenced, are detailed and have shifted over time, so this is an area to confirm carefully with local counsel. We cover the mechanics in our guide to ANVISA prior consent for pharmaceutical patents.
The utility model alternative
Alongside the patent of invention, Brazil offers a utility model (modelo de utilidade), a separate right for incremental inventions. Broadly, a utility model protects a new shape or arrangement of an object of practical use, or part of one, that results in a functional improvement in its use or manufacture. It suits practical product refinements that may not clear the inventive-step bar required for a full patent of invention. Utility models in Brazil are still examined and have their own requirements and term, which differ from those of a patent of invention; the scope of utility-model protection is jurisdiction-specific and differs between countries. Whether a patent of invention, a utility model, or both is the right call is a genuinely fact-specific judgement, and we explain the route in more detail in our guide to utility models in Brazil.
Getting to Brazil via the PCT national phase
Many foreign applicants reach Brazil through the Patent Cooperation Treaty rather than by filing directly. You file a single international (PCT) application, then later enter the Brazilian national phase, where the Brazilian INPI examines the application under its own law. This route gives you more time before committing to country-specific costs and translations, and it lets you defer the decision on whether Brazil is worth the spend. National-phase entry has its own time limit, translation requirements (a Portuguese translation of the application) and formalities. We explain the international route in general in our overview of the PCT national phase. National-phase deadlines are strict and counted from your priority date, and missing them generally forfeits the right to a patent in Brazil, so treat the specific deadline and translation rules as confirm-with-counsel details because they are precise and consequential.
Patent term and maintenance annuities
A Brazilian patent runs for a defined term and is kept in force by paying periodic maintenance fees, known as annuities, throughout its life. Missing an annuity can cause the right to lapse, so diarising these payments is part of owning a Brazilian patent. One point to state cautiously: in 2021 the Brazilian Supreme Court (the STF) struck down a provision that had guaranteed a minimum patent term running from grant, which had operated as a form of term extension where examination was slow. That provision was subsequently repealed by statute the same year, so the minimum-term top-up no longer exists at all; the transitional treatment of already-granted patents was complex. The practical effect was to change how the term of affected patents is calculated, so do not rely on any particular term calculation here; confirm the current position for your specific patent with the Brazilian INPI or qualified local counsel. Official fees apply to filing, examination and annuities; confirm the current amount with the Brazilian INPI or local counsel.
A note on using this information
This overview is general information about the Brazilian patent system and is not legal advice. IPEnvoy is not a law firm and does not provide legal advice. Patent law in Brazil is detailed and changes, and the deadlines, terms, fees and ongoing reforms described here in general terms should be confirmed against the Brazilian INPI's official website or with a qualified local IP professional before you act. Where it helps, IPEnvoy can route you to vetted local counsel in Brazil who can assess your specific position and handle filing, examination and enforcement.